Steve A. Herweck,Joseph Ferraro,Paul Martakos,Theodore Karwoski,Anthony Richard Horton
申请号：
US12075223
公开号：
US09801982B2
申请日:
2008.03.10
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A barrier device is formed of a barrier component that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. The barrier component can be a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The barrier device can have anchoring locations to provide an area on the barrier device to interface with an anchoring mechanism. The anchoring locations can include openings and/or anchor elements. The barrier device can also include truss structures that provide additional strength to the barrier component. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.
